A parallel effect was observed in glioblastoma as revealed by Mahlokozera, Patel et al. who found that TRIM26 stabilizes SOX2 protein and enhances its oncogenic activity in glioblastoma via its C-terminal PRYSPRY domain without engaging its Ring domain and E3 ligase activity (11). Here, SOX2 is linked to glioblastoma.